Skip to main content
Industry News
White House taps Va. firm to manufacture COVID-19 drugs

HHS' Biomedical Advanced Research and Development Authority awarded a four-year contract worth $354 million to Virginia-based Phlow to manufacture medicines and active pharmaceutical ingredients needed to combat COVID-19 as part of the administration's effort to reduce the country's reliance on foreign manufacturing. The contract can be extended for up to $812 million over 10 years.

Full Story: